NCT00613964View on ClinicalTrials.gov

The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure

PHASE4TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Heart FailureRenal Failure
Interventions
DRUG

Carperitide heart failure therapy

carperitide(alpha-human atrial natriuretic peptide, 0.025-0.05μg/kg/min)

DRUG

Standard heart failure therapy

Loop diuretics, Aldosterone blockers, Beta blockers, ACE inhibitors, Angiotensin receptor blockers, Nitrates, digitalis

Trial Locations (1)

634-8522

First Department of Internal Medicine, Nara Medical University, Nara

Sponsors
All Listed Sponsors
lead

Nara Medical University

OTHER

NCT00613964 - The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure | Biotech Hunter | Biotech Hunter